Kandeel Mahmoud, Marzok Mohamed, Afzal Sheryar, Meligy Ahmed, Mahmoud Maryam, Albokhadaim Ibrahim, Khodair Khalid M Al, Alhojaily Sameer
Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-Hofuf, Al-Ahsa, Saudi Arabia.
Department of Clinical Sciences, College of Veterinary Medicine, King Faisal University, Al-Hofuf, Al-Ahsa, Saudi Arabia.
Pain Res Manag. 2025 Aug 18;2025:8881632. doi: 10.1155/prm/8881632. eCollection 2025.
Myofascial pain syndrome (MPS) is a prevalent musculoskeletal disorder characterized by myofascial trigger points (MTrPs), which can significantly impact an individual's quality of life. This study aimed to evaluate the efficacy of Kinesio taping (KT) in reducing pain intensity and increasing pressure pain threshold (PPT) in individuals with MPS. A comprehensive search was performed across five electronic databases (PubMed, Web of Science, Cochrane Library, Embase, and SCOPUS) from inception to May 2024. Randomized controlled trials (RCTs) comparing KT to a control group, including no intervention, placebo, or sham taping, in individuals with MPS were included. Data on pain intensity and PPT were extracted and pooled using RevMan 5.4 software. A total of 15 RCTs were included in the systematic review and meta-analysis. The pooled analysis showed a significant reduction in pain intensity in the KT group compared to the control group immediately after intervention (mean difference [MD] = -1.07, 95% confidence interval (CI) [-1.93, -0.20], = 0.02), within the first week (standardized mean difference [SMD] = -1.44, 95% CI [-2.39, -0.49], = 0.003), and after 2-3 weeks (SMD = -0.97, 95% CI [-1.46, -0.49], < 0.0001). However, the effect diminished after 4-6 weeks (MD = -0.90, 95% CI [-1.65, -0.14], = 0.02). Regarding PPT, KT significantly increased PPT within the first week (MD = 4.32, 95% CI [2.47, 6.16], < 0.00001) but not immediately after intervention or after 2-3 and 4-6 weeks. This meta-analysis provides evidence that KT is effective in reducing pain intensity and increasing PPT in individuals with MPS, particularly in the immediate and short-term periods. However, the effects on pain reduction and PPT diminish over time, suggesting a need for reapplication or combination with other interventions for sustained long-term benefits.
肌筋膜疼痛综合征(MPS)是一种常见的肌肉骨骼疾病,其特征为肌筋膜触发点(MTrP),会对个人生活质量产生重大影响。本研究旨在评估肌内效贴布(KT)对减轻MPS患者疼痛强度及提高压力疼痛阈值(PPT)的疗效。从数据库建库至2024年5月,对五个电子数据库(PubMed、科学网、考克兰图书馆、Embase和Scopus)进行了全面检索。纳入了比较KT与对照组(包括无干预、安慰剂或假贴布)对MPS患者疗效的随机对照试验(RCT)。使用RevMan 5.4软件提取并汇总疼痛强度和PPT的数据。系统评价和荟萃分析共纳入15项RCT。汇总分析显示,与对照组相比,KT组在干预后即刻疼痛强度显著降低(平均差值[MD]= -1.07,95%置信区间[CI][-1.93, -0.20],P = 0.02),在第一周内(标准化平均差值[SMD]= -1.44,95% CI [-2.39, -0.49],P = 0.003),以及在2 - 3周后(SMD = -0.97,95% CI [-1.46, -0.49],P < 0.0001)。然而,在4 - 6周后效果减弱(MD = -0.90,95% CI [-1.65, -0.14],P = 0.02)。关于PPT,KT在第一周内显著提高了PPT(MD = 4.32,95% CI [2.47, 6.16],P < 0.00001),但在干预后即刻、2 - 3周以及4 - 6周后未出现显著变化。这项荟萃分析提供了证据,表明KT对减轻MPS患者的疼痛强度和提高PPT有效,尤其是在即刻和短期内。然而,随着时间推移,其对疼痛减轻和PPT的效果会减弱,这表明需要重新应用或与其他干预措施联合使用以获得持续的长期益处。
Cochrane Database Syst Rev. 2021-8-8
Cochrane Database Syst Rev. 2018-3-16
Cochrane Database Syst Rev. 2018-4-13
Chiropr Man Therap. 2022-9-1
Cochrane Database Syst Rev. 2014-7-25
J Bodyw Mov Ther. 2016-7
J Back Musculoskelet Rehabil. 2022
Int J Environ Res Public Health. 2023-2-22
Healthcare (Basel). 2022-8-7
Turk J Phys Med Rehabil. 2021-3-4